[Adherence to neurologic treatment. Lessons from multiple sclerosis]
- PMID: 18335191
- DOI: 10.1007/s00115-008-2419-0
[Adherence to neurologic treatment. Lessons from multiple sclerosis]
Abstract
In light of increasing prevalence rates of chronic conditions and a growing elderly population, patients' nonadherence to medical regimes reflects a significant problem in modern health care. In the past, patients were primarily held responsible for problematic adherence. Over the past decades this attitude has changed dramatically, and it is now acknowledged that lack of adherence reflects a problem requiring different approaches and interventions on many different levels. Here we highlight central aspects and consequences of adherence problems in long-term therapy. Factors affecting treatment motivation in multiple sclerosis patients are summarized focusing on neurologic treatment issues, and specific intervention strategies for patients, doctors, and nurses are discussed.
Similar articles
-
Compliance, adherence, and the treatment of multiple sclerosis.J Neurol. 2008 Dec;255 Suppl 6:87-92. doi: 10.1007/s00415-008-6016-8. J Neurol. 2008. PMID: 19300966 Review.
-
[The nurse's role in multiple sclerosis treatment adherence].Soins. 2006 Oct;(709):24-9. Soins. 2006. PMID: 17111862 Review. French. No abstract available.
-
The importance of physician-patient relationship for improvement of adherence to long-term therapy: data of survey in a cohort of multiple sclerosis patients with mild and moderate disability.Neurol Sci. 2012 Jun;33(3):575-84. doi: 10.1007/s10072-011-0776-0. Epub 2011 Sep 17. Neurol Sci. 2012. PMID: 21927880
-
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.Expert Rev Neurother. 2014 Sep;14(9):1029-42. doi: 10.1586/14737175.2014.945523. Epub 2014 Aug 11. Expert Rev Neurother. 2014. PMID: 25109614 Review.
-
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes--an orchestrated approach.J Neurol Sci. 2013 Dec 15;335(1-2):1-4. doi: 10.1016/j.jns.2013.08.025. Epub 2013 Aug 30. J Neurol Sci. 2013. PMID: 24041734 Review.
Cited by
-
Development of Registry Data to Create Interactive Doctor-Patient Platforms for Personalized Patient Care, Taking the Example of the DESTINY System.Front Digit Health. 2021 Mar 22;3:633427. doi: 10.3389/fdgth.2021.633427. eCollection 2021. Front Digit Health. 2021. PMID: 34713104 Free PMC article. Review.
-
Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.BMC Neurol. 2016 Sep 21;16(1):181. doi: 10.1186/s12883-016-0705-1. BMC Neurol. 2016. PMID: 27653529 Free PMC article.
-
QualiCOP: real-world effectiveness, tolerability, and quality of life in patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate, treatment-naïve patients, and previously treated patients.J Neurol. 2016 Apr;263(4):784-91. doi: 10.1007/s00415-016-8058-7. Epub 2016 Feb 25. J Neurol. 2016. PMID: 26914926
-
REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program.Neurol Ther. 2024 Jun;13(3):641-653. doi: 10.1007/s40120-024-00593-x. Epub 2024 Mar 26. Neurol Ther. 2024. PMID: 38530606 Free PMC article.
-
Improving patient-physician dialog: commentary on the results of the MS Choices survey.Patient Prefer Adherence. 2012;6:143-52. doi: 10.2147/PPA.S27932. Epub 2012 Feb 17. Patient Prefer Adherence. 2012. PMID: 22379365 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous